
A physician collaborating with a Kentucky NP must be licensed in Kentucky and enter the appropriate written agreement—CAPA‑NS for nonscheduled legend drugs or the standardized Form CAPA‑CS for controlled substances—with the APRN12. In both arrangements, the physician must be in the same or a similar specialty as the APRN34. Both agreements must be reviewed by the parties and are not a substitute for the physician’s independent professional judgment5678.
For CAPA‑NS (nonscheduled legend drugs), the collaboration agreement must910:
In Kentucky, “collaboration” means a relationship for prescribing that includes autonomous and cooperative decision‑making by both professionals, each contributing their expertise11.
For CAPA‑CS (controlled substances), physicians must use the Board’s standardized Form CAPA‑CS, and ensure it21213:
At the outset of a CAPA‑CS, the APRN and collaborating physician must review all statutes and regulations governing APRN controlled‑substance prescribing14. During the first year of a CAPA‑CS, the parties must meet at least quarterly (in person or via video, with telephonic option if infeasible) to review the APRN’s reverse KASPER/PDMP report and keep written records subject to audit; in years two through four, meetings must occur at least biannually1516. Either party may rescind the CAPA‑CS with 30 days’ registered‑mail notice; upon rescission, the APRN must notify the Board and the Board will notify the medical board6.